Cargando…
Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells
BACKGROUND: Receptor for hyaluronan-mediated motility (RHAMM), one of the major hyaluronic acid (HA) receptors, is upregulated in several forms of cancer and is a poor prognostic factor for non-small cell lung cancer (NSCLC) adenocarcinoma. RHAMM is also a potential therapeutic target for inhibition...
Autores principales: | Gao, Chunzi, Liu, Shilong, Wang, Yanli, Cha, Geqi, Xu, Xiangying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798256/ https://www.ncbi.nlm.nih.gov/pubmed/35116773 http://dx.doi.org/10.21037/tcr.2019.02.03 |
Ejemplares similares
-
The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism
por: Zou, Kun, et al.
Publicado: (2015) -
The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury
por: Cui, Zheng, et al.
Publicado: (2018) -
Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer
por: Tang, Yan-ping, et al.
Publicado: (2021) -
Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor
por: He, Zhengcheng, et al.
Publicado: (2020) -
Correction. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Publicado: (1992)